.png){kind=logo}
Sigma Aldrich (10,686)
5-Aminolevulinic acid-¹³C₅, ¹⁵N hydrochloride
99 atom % ¹³C, 98 atom % ¹⁵N, 97% (CP)MF: ¹³C₅H₁₀Cl¹⁵NO₃ / MW: 173.55
Lithocholic-2,2,4,4-d₄ acid 3-sulfate disodium salt
≥98 atom % D, ≥98% (CP)MF: C₂₄D₄H₃₄Na₂O₆S / MW: 504.62
Ethylbenzene solution
suitable for NMR (reference standard), 10% in chloroform-d (99.8 atom % D), NMR tube size 10 mm × 8 in.CAS No: 100-41-4 / MF: C₈H₁₀ / MW: 106.17
Iodomethane-¹²C,d₃
99.9 atom % ¹²C, 98 atom % D, 99% (CP), contains copper as stabilizerCAS No: 865-50-9 / MF: ¹²CD₃I / MW: 144.95
Diethyl (phenylsulfinylmethyl-¹³C)phosphonate
99 atom % ¹³CMF: ¹³CC₁₀H₁₇O₄PS / MW: 277.28
Clodinafop-propargyl-(phenoxy-¹³C₆)
≥98 atom % ¹³C, ≥98% (CP)MF: ¹³C₆C₁₁H₁₃ClFNO₄ / MW: 355.70
Deoxycholic-2,2,4,4-d₄ acid 3-sulfate disodium salt
≥98 atom % D, ≥98% (CP)MF: C₂₄D₄H₃₄O₇SNa₂ / MW: 520.62
Taurolithocholic-2,2,4,4-d₄ acid 3-sulfate disodium salt
≥98 atom % D, ≥98% (CP)MF: C₂₆D₄H₃₉NO₈S₂Na₂ / MW: 611.76
Diethyl (phenylsulfonylmethyl-¹³C)phosphonate
99 atom % ¹³CCAS No: 1190788-54-5 / MF: ¹³CC₁₀H₁₇O₅PS / MW: 293.28
2-Keto-3-(methyl-d₃)-butyric acid-4-¹³C,3-d sodium salt
99 atom % ¹³C, 97 atom % D, 97% (CP)MF: ¹³CC₄H₃D₄NaO₃ / MW: 143.11
Cortisone-2,3,4-¹³C₃ 21-sulfate sodium salt solution
100 μg/mL in methanol, ≥98 atom % ¹³C, ≥95% (CP)MF: ¹³C₃C₁₈H₂₇NaO₈S / MW: 465.47
4-Fluorobenzoic acid-α-¹³C-2,3,5,6-d₄
99 atom % ¹³C, 98 atom % DCAS No: 285977-82-4 / MF: ¹³CC₆D₄HFO₂ / MW: 145.13
Chloroform solution
suitable for NMR (reference standard), 0.3% in acetone-d₆ (99.9 atom % D), NMR tube size 3 mm × 8 in.
L-Lactic acid-3-¹³C
99 atom % ¹³C, 98% (CP), ≥99% (Chiral Purity)CAS No: 155307-62-3 / MF: ¹³CC₂H₆O₃ / MW: 91.07
Stearoyl-¹³C₁₈ coenzyme A lithium salt
99 atom % ¹³C, 95% (CP)MF: ¹³C₁₈C₂₁H₇₀N₇O₁₇P₃S · xLi⁺ / MW: 1051.86 (free acid basis)
Sodium acetate-¹³C₂
endotoxin tested, 99 atom % ¹³CCAS No: 56374-56-2 / MF: ¹³C₂H₃NaO₂ / MW: 84.02
Ursodeoxycholic-2,2,4,4-d₄ acid 3-sulfate disodium salt
≥98 atom % D, ≥98%MF: C₂₄D₄H₃₄Na₂O₇S / MW: 520.62
Cholic-2,2,4,4-d4 acid 3-sulfate disodium salt
≥98 atom % D, ≥98% (CP)MF: C₂₄D₄H₃₄Na₂O₈S / MW: 536.62
Glycochenodeoxycholic-2,2,4,4-d₄ acid 3-sulfate disodium salt
≥98 atom % D, ≥98% (CP)MF: C₂₆D₄H₃₇NO₈SNa₂ / MW: 577.67
N,N-Dimethyl-d₆-formamide
≥98 atom % D, ≥98% (CP)CAS No: 185990-36-7 / MF: C₃D₆HNO / MW: 79.13
Glycolithocholic-2,2,4,4-d₄ acid solution
100 μg/mL in methanol, ≥98 atom % D, ≥98% (CP)MF: C₂₆D₄H₃₉NO₄ / MW: 437.65
2-Keto-3-(methyl-¹³C,d₁)-butyric-3,4,4,4-d4 acid sodium salt
98 atom % D, 99 atom % ¹³C, 97% (CP)MF: CD₃CD¹³CDH₂COCO₂Na / MW: 144.12
1-Ethyl-3-methylimidazolium chloride-d₁₁
98 atom % DCAS No: 160203-52-1 / MF: C₆D₁₁ClN₂ / MW: 157.69
Vitamin D₃-6,19,19-d₃ sulfate sodium salt solution
100 μg/mL in ethanol, 98 atom % D, 97% (CP)MF: C₂₇D₃H₄₀O₄SNa / MW: 489.70
Tetrahydrocortisone-2,2,3,4,4-d₅ solution
100 μg/mL in methanol, ≥98 atom % D, ≥98% (CP)MF: C₂₁D₅H₂₇O₅ / MW: 369.51
Iodomethane-¹³C solution
suitable for NMR (reference standard), 1% in chloroform-d (100%, 99.96 atom % D), chromium (III) acetylacetonate 0.2 %, trimethyl phosphite 1 %, 99 atom % ¹³C, NMR tube size 6.5 mm × 8 in.MF: ¹³CH₃I / MW: 142.93
Vitamin K₂ (MK-9)-4′,5,6,7,8,8′-¹³C₆
≥99 atom % ¹³C, ≥95% (CP)MF: ¹³C₆C₅₀H₈₀O₂ / MW: 791.19
17α-Methyl-5β-androstan-3α,17β-diol-20,20,20-d₃
≥98 atom % D, ≥95% (CP)MF: C₂₀H₃₁D₃O₂ / MW: 309.50
ᴅʟ-Lysine-1,2-¹³C₂ dihydrochloride
99 atom % ¹³CCAS No: 286437-16-9 / MF: ¹³C₂C₄H₁₄N₂O₂ · 2HCl / MW: 221.09
Riboflavin-(dioxopyrimidine-¹³C₄,¹⁵N₂) 5′-phosphate sodium salt
≥98 atom %, ≥90% (CP)MF: ¹³C₄C₁₃H₂₀¹⁵N₂N₂O₉P·Na / MW: 484.28
Vitamin D₃ solution
100 μg/mL in ethanol, 97% (CP)CAS No: 67-97-0 / MF: C₂₇H₄₄O / MW: 384.64
Diethyl 2-phthalimidomalonate-2-¹³C
99 atom % ¹³CCAS No: 92096-47-4 / MF: ¹³C₁₅H₁₅NO₆ / MW: 320.17
Glycocholic-2,2,4,4-d₄ acid 3-sulfate disodium salt
≥98 atom % D, ≥98% (CP)MF: C₂₆D₄H₃₇NNa₂O₉S / MW: 593.67
α-Tocopherol-(trimethyl-¹³C₃ phenyl)
≥99 atom % ¹³C, ≥96% (CP)MF: ¹³C₃C₂₆H₅₀O₂ / MW: 433.68
ᴅ-Glucose-¹³C₆
endotoxin tested, 99 atom % ¹³CCAS No: 110187-42-3 / MF: ¹³C₆H₁₂O₆ / MW: 186.11
Iodomethane-¹³C,d₂
≥98 atom % ¹³C, ≥98 atom % D, ≥99% (CP), contains copper as stabilizerCAS No: 207507-22-0 / MF: ¹³CD₂HI / MW: 144.94
Glycoursodeoxycholic-2,2,4,4-d₄ acid solution
100 μg/mL in methanol, ≥98 atom % D, ≥97% (CP)MF: C₂₆D₄H₃₉NO₅ / MW: 453.65
1,7-Dimethylxanthine-2,4,5,6-¹³C₄-1,3,9-¹⁵N₃
≥98 atom %, ≥98% (CP)CAS No: 1173018-79-5 / MF: ¹³C₄C₃H₈¹⁵N₃NO₂ / MW: 187.11
18-Hydroxycorticosterone-9,11,12,12-d₄
≥98 atom % D, ≥95% (CP)CAS No: 1257742-38-3 / MF: C₂₁D₄H₂₆O₅ / MW: 366.48
11-Deoxycortisol-2,3,4-¹³C₃ solution
100 μg/mL in methanol, ≥98 atom % ¹³C, ≥97% (CP)MF: ¹³C₃C₁₈H₃₀O₄ / MW: 349.44
2-Methylglutaric-4,5-¹³C₂ acid solution
1 mg/mL in methanol, ≥98 atom % ¹³C, ≥95% (CP)MF: ¹³C₂C₄H₁₀O₄ / MW: 148.13
Ethylbenzene solution
suitable for NMR (reference standard), 0.1% in chloroform-d (100%, 99.96 atom % D)CAS No: 100-41-4 / MF: C₈H₁₀ / MW: 106.17
7-Dehydrocholesterol-25,26,26,26,27,27,27-d₇
≥99 atom % D, ≥98% (CP)CAS No: 388622-58-0 / MF: C₂₇D₇H₃₇O / MW: 391.68
Adenosine-¹³C₁₀,¹⁵N₅
≥98 atom %, ≥95% (CP)CAS No: 202406-75-5 / MF: ¹³C₁₀H₁₃¹⁵N₅O₄ / MW: 282.13
DMT-2′O-TBDMS-rU-1,3-¹⁵N₂ phosphoramidite
≥98 atom % ¹⁵N, ≥95% (CP)MF: C₄₅H₆₁¹⁵N₂N₂O₉PSi / MW: 863.03
Thymidine-¹³C₁₀,¹⁵N₂ 5′-monophosphate disodium salt solution
100 mM (in 5mM Tris HCl / H₂O), ≥98 atom %, ≥95% (CP)MF: ¹³C₁₀H₁₃¹⁵N₂Na₂O₈P / MW: 378.09
DMT-2′O-TBDMS-rU-3-¹⁵N phosphoramidite
≥98 atom % ¹⁵N, ≥95% (CP)MF: C₄₅H₆₁¹⁵NN₃O₉PSi / MW: 862.04
Ethylene-d₄ oxide
≥98 atom % D, ≥99% (CP), contains hydroquinone as stabilizerCAS No: 6552-57-4 / MF: C₂D₄O / MW: 48.08
Gadolinium(III) chloride solution
suitable for NMR (reference standard), 0.1 mg/mL in D₂O (99.9 atom % D), water 0.1 %, NMR tube size 6.5 mm × 8 in.CAS No: 10138-52-0 / MF: Cl₃Gd / MW: 263.61
Sodium taurochenodeoxycholate-2,2,3,4,4,6,6,7,8-d₉ solution
100 μg/mL in methanol, ≥98 atom % D, ≥98% (CP)MF: C₂₆D₉H₃₅NO₆SNa / MW: 530.74
Chenodeoxycholic-2,2,4,4-d₄ acid 3-sulfate disodium salt
≥98 atom % D, ≥98% (CP)MF: C₂₄D₄H₃₄O₇SNa₂ / MW: 520.62
Cytidine-¹³C₉,¹⁵N₃ 5′-monophosphate disodium salt solution
100 mM (in 5mM Tris HCl / H₂O), ≥98 atom %, ≥95% (CP)MW: 379.07
Cholesteryl-25,26,26,26,27,27,27-d7 sulfate sodium salt
≥98 atom % D, ≥98% (CP)MF: C₂₇D₇H₃₈O₄SNa / MW: 495.74
Sodium taurochenodeoxycholate-2,2,4,4-d₄
≥98 atom % D, ≥97% (CP)MF: C₂₆D₄H₄₀NNaO₆S / MW: 525.71
Sodium taurochenodeoxycholate-2,2,3,4,4,6,6,7,8-d₉
≥98 atom % D, ≥98% (CP)MF: C₂₆D₉H₃₅NaNO₆S / MW: 530.74
Glycolithocholic-2,2,4,4-d₄ acid 3-sulfate disodium salt
≥98 atom % D, ≥98% (CP)MF: C₂₆D₄H₃₇NO₇SNa₂ / MW: 561.68
Guanosine-¹³C₁₀,¹⁵N₅ 5′-monophosphate disodium salt solution
100 mM (in 5mM Tris HCl / H₂O), ≥98 atom %, ≥95% (CP)MW: 422.08
ʟ-Malic acid-¹³C₄
≥99 atom % ¹³C, ≥97% (CP)CAS No: 150992-96-4 / MF: ¹³C₄H₆O₅ / MW: 138.06